Research & Development

Innovation at the core

Fortimedix Surgical is committed to driving the evolution of minimally invasive surgery through smart innovation across surgical specialties. As a technology-driven company dedicated to improving the quality of life of patients throughout the world we identify and address unmet needs in human healthcare, a strategy that is well-integrated into our research and development approach.

The symphonX™ Surgical Platform is our first commercial platform for minimally invasive surgery, and is FDA cleared for use in abdominal laparoscopic surgery. Beyond the initial focus on general surgery, symphonX™ has been successfully employed in several gynecologic procedures, including tubal sterilization and ovarian cyst treatment, confirming the versatility of the platform for other surgical applications. Gynecologic indications will be further investigated and are expected to be commercially pursued as early as the second half of 2017.

Upcoming developments

Under the leadership and guidance of Dr. Karl-Hermann Fuchs, one of our Scientific Advisory Board members, we are developing a surgical solution for less invasive transcolonic colon resection. Together with his son, Dr. Hans F. Fuchs, several cadaver and dry lab studies were performed with a modified version of the symphonX™ Surgical Platform. As part of the Emerging Technology Session of the SAGES 2016 Annual Meeting in Boston (March 2016), Dr. Hans F. Fuchs presented these results (“Initial in vitro feasibility and cadaver study results for colorectal surgery in a transanal approach”) during a podium presentation.

Certain statements herein include “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “project” or “continue” or the negative thereof or other similar words.

All forward looking statements involve risks and uncertainties, including, but not limited to, the protection of intellectual property, changes to governmental regulation of medical devices, the introduction of new products into the marketplace by competitors, changes to the competitive environment, the acceptance of new products in the marketplace, conditions of the surgical industry and economic and political conditions globally.

Actual results may differ materially from those contemplated or implied by the forward-looking statements. The forward-looking statements speak only as of the date of this release and Fortimedix Surgical assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.

By using our website you consent to all cookies in accordance with our Cookie Policy.